slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 226,561-226,590
Pages 10,126
Rows per page 30
Component
226,561-226,590 of 303,780
46
The slide presents clinical data for a small sample size (n=4) in a highly pre-treated patient population.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
47
Shows two parallel tracks: monotherapy and combination therapy with tislelizumab.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
48
Immix Biopharma | Investor Presentation Deck | 61 slidesImmix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
51
Includes technical diagrams of the drug delivery vehicle and comparative histology/survival data.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
52
Includes two sets of charts: tumor volume over time and survival curves.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
53
Includes multiple citations and diagrams illustrating the mechanism of action and clinical efficacy.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
54
The slide uses a numbered list format to present key value propositions for the company's pipeline.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
55
Immix Biopharma | Investor Presentation Deck | 61 slidesImmix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
56
Immix Biopharma | Investor Presentation Deck | 61 slidesImmix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
57
The slide uses a serpentine process flow (1-5 left-to-right, 6-10 right-to-left).Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
58
Highlights NXC-201's lower fludarabine dose and compares infusion timing across therapies.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
59
The slide uses a combination of expert testimonials and a comparative table of clinical trials to validate the outpatient administration model.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
60
The slide uses a bar chart to contrast the combined sales of two groups of drugs, implying a large market opportunity for TSTx.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
61
The slide uses a bar chart comparison to highlight the efficacy gap between established treatments and placebo.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
01
Innoviva | Results Presentation Deck | 7 slidesInnoviva | Results Presentation Deck | 7 slides · Innoviva
Conference presentation Investor relations Beat · Attention1 hit
02
Headline doubles as action title with a positive-result takeaway; body is a pure bulleted summary with footnoted Lancet citations and Innoviva branding bottom-right.Innoviva | Results Presentation Deck | 7 slides · Innoviva
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
03
The diagram illustrates a randomized controlled trial structure.Innoviva | Results Presentation Deck | 7 slides · Innoviva
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
04
Flowchart shows patient progression from screening to dosing and categorization by infection site.Innoviva | Results Presentation Deck | 7 slides · Innoviva
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
06
The slide highlights that these secondary analyses were not powered for statistical significance.Innoviva | Results Presentation Deck | 7 slides · Innoviva
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
07
The slide uses a split-layout with key takeaways on the left and supporting clinical data tables on the right.Innoviva | Results Presentation Deck | 7 slides · Innoviva
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
01
Innoviz | Results Presentation Deck | 20 slidesInnoviz | Results Presentation Deck | 20 slides · Innoviz Technologies
Conference presentation Investor relations Beat · Setup1 hit
02
Innoviz | Results Presentation Deck | 20 slidesInnoviz | Results Presentation Deck | 20 slides · Innoviz Technologies
Conference presentation Investor relations Beat · Setup1 hit
03
Innoviz | Results Presentation Deck | 20 slidesInnoviz | Results Presentation Deck | 20 slides · Innoviz Technologies
Conference presentation Investor relations Beat · Setup1 hit
04
Innoviz | Results Presentation Deck | 20 slidesInnoviz | Results Presentation Deck | 20 slides · Innoviz Technologies
Conference presentation Investor relations Beat · Setup1 hit
18
Innoviz | Results Presentation Deck | 20 slidesInnoviz | Results Presentation Deck | 20 slides · Innoviz Technologies
Conference presentation Investor relations Loop · Why Now1 hit
20
Innoviz | Results Presentation Deck | 20 slidesInnoviz | Results Presentation Deck | 20 slides · Innoviz Technologies
Conference presentation Investor relations Beat · Closing Ask1 hit
01
Invitae | Results Presentation Deck | 27 slidesInvitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations Beat · Attention1 hit
02
Invitae | Results Presentation Deck | 27 slidesInvitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations Beat · Attention1 hit
03
Invitae | Results Presentation Deck | 27 slidesInvitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations Beat · Attention1 hit
04
Invitae | Results Presentation Deck | 27 slidesInvitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations Beat · Attention1 hit